Breast Cancer Screening Market Size, Share, Growth Analysis and Forecast 2020: Carestream Health, SINO MDT, Metaltronica, Hologic

Breast cancer is the most common and widely occurring type of cancer among women; it develops in breast tissues, usually in the ducts (tubes that carry milk to the nipple) and lobules (glands that make milk). It can also occur in the fatty tissue or fibrous connective tissue within breasts. Early diagnosis of breast cancer is important as it may prevent the condition from becoming critical and ensure a successful curable treatment. The screening methods for the diagnosis of breast cancer include mammography, magnetic resonance imaging (MRI), ultrasound, and others. The foremost goal of screening is to detect disease at its earliest and most treatable stage. The screening procedures identify the early signs of cancer, even before the symptoms begin to show.

Get sample PDF copy at: https://www.theinsightpartners.com/sample/TIPRE00009796/?openpr-10144

The global breast cancer screening market is expected to reach US$ 6,209.25 Mn by 2027 from US$ 4,638.63 Mn in 2019; it is estimated to grow at a CAGR of 4.8% from 2020 to 2027.

Leading companies operating in the breast cancer screening market are Koninklijke Philips N.V.,., Hologic, Inc.,., BD, Myriad Genetics, Inc.,, Inc., Siemens Healthineers AG, Exact Sciences Corporation, Oncocyte Corporation, Poc Medical systems, Danaher, and General Electric Company, among others.

These companies are focused on adopting organic strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in June 2017, Siemens Healthineers received Food and Drug Administration (FDA) approval for its product namely syngo.via VB20 which is likely to used for Molecular Imaging (MI). This launch is a new release of the company's established intelligent visualization software for multi-modality imaging.

The breast cancer screening market, by test type, is segmented into blood marker tests, imaging test, genetic test, and immunohistochemistry test. The imaging test segment held the largest share of the market in 2019; moreover, it is also anticipated to register the highest CAGR of 5.4% during the forecast period. Thus, advancement in technology of the imaging test for screening of breast cancer is leading to boost the growth of imaging test in the breast cancer screening market

Table Of Contents:

1.1. Scope Of The Study
2. Key Takeaways
3. Research Methodology
4. Breast Cancer Screening Market Landscape
5. Breast Cancer Screening Market - Key Market Dynamics
6. Breast Cancer Screening Market - Global Market Analysis
7. Breast Cancer Screening Market - Revenue And Forecasts To 2027 - Screening Test
8. Breast Cancer Screening Market - Revenue And Forecasts To 2027 - End User
9. Breast Cancer Screening Market Revenue And Forecasts To 2027 - Geographical Analysis
10. Industry Landscape
11. Breast Cancer Screening Market, Key Company Profiles

Buy Complete Report at: https://www.theinsightpartners.com/buy/TIPRE00009796/?openpr-10144

533, 5th Floor,
Amanora Chambers, East Block, Amanora Township,
Kharadi Road, Hadapsar, Pune-411028

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.